Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000996166 | SCV001150734 | uncertain significance | not provided | 2019-04-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002479173 | SCV002787805 | uncertain significance | Polycystic kidney disease, adult type | 2021-12-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323778 | SCV004028831 | uncertain significance | not specified | 2023-07-14 | criteria provided, single submitter | clinical testing | Variant summary: PKD1 c.2728G>A (p.Asp910Asn) results in a conservative amino acid change located in the PKD domain (IPR000601) and the cation channel domain (IPR006228) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 248432 control chromosomes (i.e., 1 heterozygote; gnomAD v2.1, Exomes dataset). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2728G>A in individuals affected with Polycystic Kidney Disease 1 and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |